In line with this, we demonstrate that the rVAR2-enriched CTC population from cancer patients contains vimentin-positive cells as well as EpCAM-negative cells, indicating that the rVAR2 isolates include mesenchymal-like subpopulations. This evidence concerns the gene VIM and cancer.